To determine whether JNK1 or JNK2 selectively contributes to TGF-β–induced myelofibrosis, we used CRISPR/Cas9 gene editing to delete Mapk8 (JNK1) or Mapk9 (JNK2) in MSCs. This evidence concerns the gene MAPK9 and myelofibrosis.